Literature DB >> 9129544

The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules.

S J Swensen1, M D Silverstein, D M Ilstrup, C D Schleck, E S Edell.   

Abstract

BACKGROUND: A clinical prediction model to identify malignant nodules based on clinical data and radiological characteristics of lung nodules was derived using logistic regression from a random sample of patients (n = 419) and tested on data from a separate group of patients (n = 210).
OBJECTIVE: To use multivariate logistic regression to estimate the probability of malignancy in radiologically indeterminate solitary pulmonary nodules (SPNs) in a clinically relevant subset of patients with SPNs that measured between 4 and 30 mm in diameter. PATIENTS AND METHODS: A retrospective cohort study at a multispecialty group practice included 629 patients (320 men, 309 women) with newly discovered (between January 1, 1984, and May 1, 1986) 4- to 30-mm radiologically indeterminate SPNs on chest radiography. Patients with a diagnosis of cancer within 5 years prior to the discovery of the nodule were excluded. Clinical data included age, sex, cigarette-smoking status, and history of extrathoracic malignant neoplasm, asbestos exposure, and chronic interstitial or obstructive lung disease; chest radiological data included the diameter, location, edge characteristics (eg, lobulation, spiculation, and shagginess), and other characteristics (eg, cavitation) of the SPNs. Predictors were identified in a random sample of two thirds of the patients and tested in the remaining one third.
RESULTS: Sixty-five percent of the nodules were benign, 23% were malignant, and 12% were indeterminate. Three clinical characteristics (age, cigarette-smoking status, and history of cancer [diagnosis, > or = 5 years ago]) and 3 radiological characteristics (diameter, spiculation, and upper lobe location of the SPNs) were independent predictors of malignancy. The area (+/-SE) under the evaluated receiver operating characteristic curve was 0.8328 +/- 0.0226.
CONCLUSION: Three clinical and 3 radiographic characteristics predicted the malignancy in radiologically indeterminate SPNs.

Entities:  

Mesh:

Year:  1997        PMID: 9129544

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  214 in total

1.  Management of solitary pulmonary nodules: how do thoracic computed tomography and guided fine needle biopsy influence clinical decisions?

Authors:  D R Baldwin; T Eaton; J Kolbe; T Christmas; D Milne; J Mercer; E Steele; J Garrett; M L Wilsher; A U Wells
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

2.  Solid pulmonary nodule risk assessment and decision analysis: comparison of four prediction models in 285 cases.

Authors:  Simone Perandini; Gian Alberto Soardi; Massimiliano Motton; Arianna Rossi; Manuel Signorini; Stefania Montemezzi
Journal:  Eur Radiol       Date:  2015-12-08       Impact factor: 5.315

3.  Improved pulmonary nodule classification utilizing quantitative lung parenchyma features.

Authors:  Samantha K N Dilger; Johanna Uthoff; Alexandra Judisch; Emily Hammond; Sarah L Mott; Brian J Smith; John D Newell; Eric A Hoffman; Jessica C Sieren
Journal:  J Med Imaging (Bellingham)       Date:  2015-09-01

4.  Diagnostic evaluation following a positive lung screening chest radiograph in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial.

Authors:  William G Hocking; Martin C Tammemagi; John Commins; Martin M Oken; Paul A Kvale; Ping Hu; Lawrence R Ragard; Tom L Riley; Paul Pinsky; Thomas M Beck; Philip C Prorok
Journal:  Lung Cancer       Date:  2013-08-07       Impact factor: 5.705

5.  An Official American Thoracic Society Research Statement: A Research Framework for Pulmonary Nodule Evaluation and Management.

Authors:  Christopher G Slatore; Nanda Horeweg; James R Jett; David E Midthun; Charles A Powell; Renda Soylemez Wiener; Juan P Wisnivesky; Michael K Gould
Journal:  Am J Respir Crit Care Med       Date:  2015-08-15       Impact factor: 21.405

Review 6.  Implementing lung cancer screening in the real world: opportunity, challenges and solutions.

Authors:  Robert J Optican; Caroline Chiles
Journal:  Transl Lung Cancer Res       Date:  2015-08

7.  Evaluation of models for predicting the probability of malignancy in patients with pulmonary nodules.

Authors:  You Li; Hui Hu; Ziwei Wu; Ge Yan; Tangwei Wu; Shuiyi Liu; Weiqun Chen; Zhongxin Lu
Journal:  Biosci Rep       Date:  2020-02-28       Impact factor: 3.840

8.  Safety and effectiveness of stereotactic body radiotherapy for a clinically diagnosed primary stage I lung cancer without pathological confirmation.

Authors:  Katsuyuki Sakanaka; Yukinori Matsuo; Yasushi Nagata; Sayo Maki; Keiko Shibuya; Yoshiki Norihisa; Masaru Narabayashi; Nami Ueki; Takashi Mizowaki; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2013-11-12       Impact factor: 3.402

9.  Predictive Accuracy of the PanCan Lung Cancer Risk Prediction Model -External Validation based on CT from the Danish Lung Cancer Screening Trial.

Authors:  Mathilde M Winkler Wille; Sarah J van Riel; Zaigham Saghir; Asger Dirksen; Jesper Holst Pedersen; Colin Jacobs; Laura Hohwü Thomsen; Ernst Th Scholten; Lene T Skovgaard; Bram van Ginneken
Journal:  Eur Radiol       Date:  2015-03-13       Impact factor: 5.315

10.  A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT.

Authors:  Andrew V Kossenkov; Rehman Qureshi; Noor B Dawany; Jayamanna Wickramasinghe; Qin Liu; R Sonali Majumdar; Celia Chang; Sandy Widura; Trisha Kumar; Wen-Hwai Horng; Eric Konnisto; Gerard Criner; Jun-Chieh J Tsay; Harvey Pass; Sai Yendamuri; Anil Vachani; Thomas Bauer; Brian Nam; William N Rom; Michael K Showe; Louise C Showe
Journal:  Cancer Res       Date:  2018-11-28       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.